AI-generated summary
The authors conducted a systematic review of clinical trials comparing low-level laser therapy with control treatments for recurrent herpes labialis. Of 227 retrieved articles, six trials met the eligibility criteria, and the authors qualitatively report that all six found laser effective without side effects. Because of marked heterogeneity across studies, no statistical analysis was performed, and the authors call for more well-designed randomized trials with standardized laser parameters.
- Studies included
- 6
- Who or what was studied
- Patients with recurrent herpes labialis (oro-facial herpes) in clinical trials identified from Medline/PubMed, Scopus, and Web of Science
- Wavelengths
- 632, 870 nm
- Limits stated in the abstract
- Marked heterogeneity in study designs and laser parameters, no statistical analysis was performed, and more well-designed randomized trials are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 870 nm
- Energy density (fluence)
- 48 J/cm2
- Power
- 80 W
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Systematic review, Heterogeneity, Power output. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.